Live Breaking News & Updates on Vanda pharmaceuticals

Stay informed with the latest breaking news from Vanda pharmaceuticals on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Vanda pharmaceuticals and stay connected to the pulse of your community

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Short Interest Down 16.9% in April

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Free Report) was the recipient of a large drop in short interest in April. As of April 15th, there was short interest totalling 2,070,000 shares, a drop of 16.9% from the March 31st total of 2,490,000 shares. Based on an average daily trading volume, of 2,290,000 shares, the days-to-cover […]

Los-angeles , California , United-states , Vanda-pharmaceuticals-inc , Jacobs-levy-equity-management-inc , Nasdaq , Stonepine-capital-management , Capital-partners , Acadian-asset-management , Vanda-pharmaceuticals-company-profile , News-ratings-for-vanda-pharmaceuticals-daily

Rx Rundown: Xaira Therapeutics, Ipsen, Sanofi and more

Check out this week’s medical marketing news, dealmaking and industry chatter.

Italy , San-diego , California , United-states , Switzerland , Colorado , Sweden , Bern , Ireland , Boulder , Tessera , Veneto

Vanda Pharmaceuticals (NASDAQ:VNDA) Cut to Hold at StockNews.com

Vanda Pharmaceuticals (NASDAQ:VNDA) Cut to Hold at StockNews.com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Capital-partners , Vanda-pharmaceuticals-inc , Nasdaq , Vanda-pharmaceuticals-price-performance , News-ratings-for-vanda-pharmaceuticals-daily , Stonepine-capital-management , Vanda-pharmaceuticals-company-profile , Acadian-asset-management , Exchange-traded-concepts , Vanda-pharmaceuticals , Institutional-trading-of-vanda-pharmaceuticals

Vanda Pharmaceuticals (NASDAQ:VNDA) Downgraded by StockNews.com to Hold

StockNews.com downgraded shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) from a buy rating to a hold rating in a report issued on Monday. Separately, TheStreet lowered Vanda Pharmaceuticals from a c- rating to a d rating in a research note on Thursday, February 8th. View Our Latest Analysis on VNDA Vanda Pharmaceuticals Price Performance […]

China , New-york , United-states , Switzerland , Swiss , Nasdaq , Vanda-pharmaceuticals-price-performance , News-ratings-for-vanda-pharmaceuticals-daily , Institutional-investors-weigh-in-on-vanda-pharmaceuticals , China-universal-asset-management-co , Vanda-pharmaceuticals-inc

Shareholder Capital Delivers Letter to Independent Members

Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals...

Miami , Florida , United-states , Nasdaq , Vanda-pharmaceuticals-inc , Shareholder-capital , Reminds-vanda , Their-fiduciary-duties-given , Future-pak , Acquire-vanda , Undervalued-shares

U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents

The U.S. Supreme Court
on Monday declined to hear a bid by Vanda Pharmaceuticals
to revive patents for its sleep-disorder drug Hetlioz
that were previously declared invalid in a dispute with...

Washington , United-states , Delaware , Colm-connolly , Vanda-hetlioz , Blake-brittain , Us-court , Supreme-court , Reuters , Drug-administration , Vanda-pharmaceuticals , Us-supreme-court-on

U.S. Supreme Court Rejects Vanda Pharmaceuticals Case Over Sleep-Drug Patents

U.S. Supreme Court Rejects Vanda Pharmaceuticals Case Over Sleep-Drug Patents
usnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from usnews.com Daily Mail and Mail on Sunday newspapers.

Delaware , United-states , Washington , Colm-connolly , Blake-brittain , Vanda-hetlioz , United-states-supreme-court , Reuters , Us-court , Drug-administration , Us-supreme-court-on , Supreme-court

Equities Research Analysts' Updated EPS Estimates for April 22nd (ARCH, ASND, BATS, BBSI, BHB, BME, BMTX, BP, CALX, CCL)

Equities Research Analysts’ updated eps estimates for Monday, April 22nd: Arch Resources (NYSE:ARCH) had its buy rating reiterated by analysts at Benchmark Co.. They currently have a $180.00 price target on the stock. Ascendis Pharma A/S (NASDAQ:ASND) had its equal weight rating reaffirmed by analysts at Morgan Stanley. They currently have a $116.00 price target […]

United-states , California , America , American , Roth-mkm , William-blair , Piper-sandler , Raymond-james , Ascendis-pharma , Pacific-biosciences , Barrington-research , Equities-research-analyst

Vanda Pharmaceuticals (VNDA) Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ

Vanda Pharmaceuticals (VNDA) Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Mihaelh-polymeropoulos , Teva-pharmaceuticals-united-states-inc , Apotex-inc , Vanda-pharmaceuticals-inc , Supreme-court , Apotex-corp , Vanda-pharmaceuticals , Abbreviated-new-drug-application , Teva-pharmaceuticals-united-states ,

SCOTUS Scraps Vanda's Bid for Guidance on Obviousness Standard

The U.S. Supreme Court today denied a petition for certiorari seeking clarification from the Court on the proper standard for a showing of obviousness.

United-states , American , Salix-pharmaceuticals , Us-court , American-council-of-the-blind , High-court , Supreme-court , Veterans-association , Vanda-pharmaceuticals , Us-supreme-court , Petitioner-vanda-pharmaceuticals-inc